medac integrates production sites under a unified brand

Wedel, 1 April 2026 – The medac group brings its production sites in Dessau and Brno together under the corporate brand medac. As of 1 April 2026, the former companies Oncotec Pharma Produktion GmbH and oncomed manufacturing a.s. operate under the name medac pharma production.

The new company names are:

•        medac pharma production GmbH (Dessau)

•        medac pharma production a.s. (Brno)

With this step, medac aligns its production activities under the corporate brand and establishes a clear structure within the group.

Unified brand approach strengthens the corporate presence

Following the rebranding, both production sites operate under the medac brand and apply a shared brand identity. The legal independence of the companies remains unchanged.

The harmonised brand structure provides greater transparency for partners, customers and employees worldwide and supports the long-term development of the medac group as a global pharmaceutical company.

Production in Europe for quality and reliable supply

Manufacturing in Europe has always been a core element of medac’s corporate approach. In-house production capabilities enable the company to maintain high quality standards and ensure a reliable supply of medicines for patients.

The unified naming of the production sites underlines this commitment and strengthens manufacturing capabilities within the medac group.